Italia markets close in 5 hours 1 minute

DaVita Inc. (DVA)

NYSE - NYSE Prezzo differito. Valuta in USD.
Aggiungi a watchlist
89,26-0,11 (-0,12%)
Alla chiusura: 04:00PM EDT
89,26 +0,04 (+0,04%)
Dopo ore: 04:07PM EDT
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente89,37
Aperto88,55
Denaro0,00 x 800
Lettera89,80 x 900
Min-Max giorno87,32 - 89,76
Intervallo di 52 settimane74,97 - 124,81
Volume546.566
Media Volume722.884
Capitalizzazione7,806B
Beta (5 anni mensile)1,14
Rapporto PE (ttm)10,58
EPS (ttm)8,44
Prossima data utili26 ott 2022 - 31 ott 2022
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1A100,38
  • GlobeNewswire

    Miromatrix to Ring Nasdaq Closing Bell on National Donor Day, February 14, 2022

    EDEN PRAIRIE, Minn., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients’ lives, announced that the Company will ring the closing bell at Nasdaq on Monday, February 14, 2022, at 4:00 p.m. ET to celebrate National Donor Day and the Company’s public listing last year on Nasdaq under the trading symbol MIRO. Miromatrix CEO, Jeff Ross, Ph.D., wi

  • GlobeNewswire

    Renalytix Reports Full Year Fiscal 2021 Results

    LONDON and SALT LAKE CITY, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX), (LSE: RENX) an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, announces its results for the twelve months ended 30 June 2021. Highlights: Regulatory & Reimbursement Government-wide contract granted by the U.S. General Services Administration for KidneyIntelX™ testing s